Skip to main content
Vinay Mathew Thomas
( out of 71 reviews )

Vinay Mathew Thomas, MBBS

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital North

4K, Hematology Inpatient
1950 Circle of Hope
Salt Lake City , UT 84112

Specialties

Board Certification

American Board of Internal Medicine (Internal Medicine)

Patient Rating

5.0 /5
( out of 71 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

1840-12-31 00:00:00
HUNTSMAN CANCER CENTER

Dr. Thomas It's a pleasure to work with. He is very caring and clearly an expert in his field and gives me confidence in my care.

1840-12-31 00:00:00
HUNTSMAN CANCER CENTER

Very knowledgeable and caring. Took great pains to explain all the details of the disease and treatment. His explanations gave us the information we needed to make our decision without arguing or sounding condescending.

1840-12-31 00:00:00
HUNTSMAN CANCER CENTER

I loved the time you took to connect with me non-medically. What I'm going through is very scary and to create a brief moment of connection with a brilliant physician like you helps. The mix of technical knowledge and human connection was just right for me. Of course the reason we are there is medicine. This patient appreciates the mix of personal and medicine. Both take time and I'm hoping you'll be able continue that style throughout your career.

1840-12-31 00:00:00
HUNTSMAN CANCER CENTER

Very considerate in explaining everything in terms a lay person can relate to and learn more as we go.

1840-12-31 00:00:00
HUNTSMAN CANCER CENTER

Dr Thomas is very professional, kind and compassionate.

1840-12-31 00:00:00
HUNTSMAN CANCER CENTER

Dr Thomas makes the visit very easy and pleasant and fun as he has a great sense of humor as well as being very informative and positive. He and his team were perfect for my visit

1840-12-31 00:00:00
HUNTSMAN CANCER CENTER

Have strong faith that he is sincerely committed to my successful treatments.

1840-12-31 00:00:00
HUNTSMAN CANCER CENTER

Not only is he a great Doctor, he quickly became a great friend. I have eccenually turned my future life into his hands and I am totally comfortable with this.

1840-12-31 00:00:00
HUNTSMAN CANCER CENTER

Dr. Thomas is amazing. He treats me with respect and listens to all my needs. I could not be happier with my doctor!

Board Certification and Academic Information

Academic Departments Internal Medicine -Assistant Professor (Clinical)
Academic Divisions Oncology
Board Certification
American Board of Internal Medicine (Internal Medicine)

Education history

Professional Medical Medicine - Thiruvananthapuram Medical College M.B.B.S.
Residency Internal Medicine - University of Connecticut School of Medicine Resident
Chief Resident Internal Medicine - University of Connecticut School of Medicine Chief Medical Resident
Fellowship Hematology/Oncology - Huntsman Cancer Institute, University of Utah Spencer Fox Eccles School of Medicine Fellow

Selected Publications

Journal Article

  1. McFarland TR, Mathew Thomas V, Nussenzveig R, Gebrael G, Sayegh N, Tripathi N, Sahu KK, Goel D, Maughan BL, Sirohi D, Agarwal N, Swami U (2022). Detection of BRCA1, and BRCA2 Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World Setting. Biomedicines, 10(12).
  2. Swami U, Graf RP, Nussenzveig RH, Fisher V, Tukachinsky H, Schrock AB, Li G, Ross JS, Sayegh N, Tripathi N, Mathew Thomas V, Oxnard GR, Antonarakis ES, Agarwal N (2022). SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer. Clin Cancer Res, 28(22), 4917-4925.
  3. Sayegh N, Tripathi N, Nussenzveig RH, Thomas VM, Tandar C, Goel D, Nordblad B, Sahu KK, Li H, L Maughan B, Agarwal N, Swami U (2023). Survival of Patients with Metastatic Prostate Cancer After Disease Progression on an Androgen Receptor Axis-Targeted Therapy Given in the Metastatic Castration-Sensitive Versus Metastatic Castration-Resistant Prostate Cancer Setting. Eur Urol Focus, 9(1), 106-109.
  4. Tripathi N, Jo Y, Tripathi A, Sayegh N, Li H, Nussenzveig R, Haaland B, Thomas VM, Gupta S, Maughan BL, Swami U, Pal SK, Grivas P, Agarwal N, Sirohi D (2022). Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma. Urol Oncol, 40(11), 493.e1-493.e7.
  5. Mathew Thomas V, Gilreath JA, Newton S, Smock KJ, Lim MY (2021). Daratumumab as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy. Haemophilia, 27(4), e563-e566.
  6. Mathew Thomas V, Bindal P, Ann Alexander S, McDonald K (2020). Nivolumab-induced hepatitis: A rare side effect of an immune check point inhibitor. J Oncol Pharm Pract, 26(2), 459-461.
  7. Mathew Thomas V, Bindal P, Vredenburgh JJ (2019). Everolimus and Bevacizumab in the Management of Recurrent, Progressive Intracranial NF2 Mutated Meningioma. Case Rep Oncol, 12(1), 126-130.
  8. Mathew Thomas V, Alexander SA, Bindal P, Vredenburgh J (2020). Idiopathic Granulomatous Mastitis-A Mystery Yet to be Unraveled: A Case Series and Review of Literature. Cureus, 12(2), e6895.
  9. Thomas VM, Thomas-Eapen N (2017). An Uncommon Side Effect of a Commonly Used Antibiotic: Amoxicillin-Clavulanic Acid Induced Hepatitis. Korean J Fam Med, 38(5), 307-310.
  10. Singh M, Thomas VM, Mulay S (2020). Bortezomib-induced motor neuropathy: A case report. J Oncol Pharm Pract, 26(6), 1549-1552.
  11. Alexander SA, Mathew Thomas V, Savage JA (2020). Elevated C-reactive Protein and Role of Steroids in Cocaine-associated Levamisole-induced Vasculitis. Cureus, 12(4), e7597.
  12. Chango Azanza JJ, Mathew Thomas V, Calle Sarmiento PM, Singh M, Alexander SA (2020). Spontaneous Tumor Lysis Syndrome Due to Endometrial Carcinoma. Cureus, 12(3), e7220.
  13. Li H, Sahu KK, Kumar SA, Nordblad B, Sayegh N, Tripathi N, Thomas VM, Gupta S, Maughan BL, Agarwal N, Swami U (2022). A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers. Heliyon, 8(9), e10583.
  14. Mathew Thomas V, Alexander SA, Hadfield MJ, Vredenburgh (2020). A Rare Case of Clear Cell Adenocarcinoma of the Cervix with No Intrauterine Diethylstilbestrol Exposure. Cureus, 12(4), e7796.
  15. Chango Azanza JJ, Calle Sarmiento PM, Mathew Thomas V, Lopetegui Lia N, Kidwai (2020). Tumor Lysis Syndrome Caused by Unrecognized Richter's Transformation of Chronic Lymphocytic Leukemia: Treatment With Venetoclax for Suspected Disease Progression. Cureus, 12(5), e8145.
  16. Gebrael G, Sahu KK, Chigarira B, Tripathi N, Mathew Thomas V, Sayegh N, Maughan BL, Agarwal N, Swami U, Li (2023). Enhancing Triage Efficiency and Accuracy in Emergency Rooms for Patients with Metastatic Prostate Cancer: A Retrospective Analysis of Artificial Intelligence-Assisted Triage Using ChatGPT 4.0. Cancers, 15(14),

Review

  1. Mathew Thomas V, Tripathi N, Agarwal N, Swami U (2022). Current and emerging role of sacituzumab govitecan in the management of urothelial carcinoma. [Review]. Expert Rev Anticancer Ther, 22, (4), 335-341.
  2. Thomas VM, Abou-Ismail MY, Lim MY (2022). Off-label use of emicizumab in persons with acquired haemophilia A and von Willebrand disease: A scoping review of the literature. [Review]. Haemophilia, 28, (1), 4-17.

Editorial

  1. Gebrael G, Thomas VM, Swami U, Agarwal N (2023). The Management of Metastatic Castrate-Sensitive Prostate Cancer: From Guidelines to Real-World Practice. Oncologist, 28(9), 746-749.

Letter

  1. Thomas VM, Mathew A (2020). Brain Share, Not Brain Drain. [Letter to the editor]. JCO Glob Oncol, 6, 504.